, United Nations Office on Drugs and Crime. Heroin. Bull. Narc, vol.5, pp.62-73, 1953.

P. H. Hughes and O. Rieche, Heroin epidemics revisited. Epidemiol, Rev, vol.17, pp.66-73, 1995.

S. C. Boyd, From witches to crack moms : Women, drug law, and policy, 2004.

E. Menninger-lerchenthal, The morphine disease of the newborn in morphineusing mothers. Monastscr f Kinderh, vol.60, pp.182-193, 1934.

J. J. Happel, Morphinism in its relation to the sexual functions and appetite and its effect on the off-spring of the users of the drug, Med. Surg. Rep. 1892, vol.68, pp.403-407

G. E. Pettey, Congenital morphinism, with report of cases: general treatment of morphinism, South. Med. J. 1912, vol.65, pp.37-63

M. J. Goodfriend, I. A. Shey, and M. D. Klein, The effects of maternal narcotic addiction on the newborn, Am. J. Obstet. Gynecol, vol.71, pp.29-36, 1956.

T. Rosenthal, S. W. Patrick, and D. C. Krug, Congenital neonatal narcotics addiction : a natural history, Am. J, vol.54, pp.1252-1262, 1964.

M. A. Perlstein, Congenital morphinism; a rare cause of convulsions in the newborn, J. Am. Med. Assoc, vol.135, p.633, 1947.

M. M. Desmond and G. S. Wilson, Neonatal abstinence syndrome: recognition and diagnosis, Addict. Dis, vol.2, pp.113-121, 1975.

L. P. Finnegan, J. F. Connaughton, R. E. Kron, and J. P. Emich, Neonatal abstinence syndrome: assessment and management, Addict. Dis, vol.2, pp.141-158, 1975.

P. J. Lipsitz, A proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy, Clin. Pediatr. (Phila), vol.14, pp.592-594, 1975.

D. Blinick, R. C. Wallach, E. Jerez, and B. D. Ackerman, Drug addiction in pregnancy and the neonate, Am. J. Obstet. Gynecol, vol.125, pp.135-142, 1976.

H. Joseph, S. Stancliff, and J. Langrod, Methadone maintenance treatment (MMT): a review of historical and clinical issues, Mt Sinai J. Med, vol.67, pp.347-364, 2000.

M. Auriacombe, S. Afflelou, P. Lavignasse, C. Lafitte, D. Roux et al., Pregnancy, abortion, and delivery in a cohort of heroin-dependent patients treated with drug substitution (methadone and buprenorphine) in aquitaine. Presse Méd, vol.28, p.177, 1999.

H. E. Jones, S. H. Heil, A. Baewert, A. M. Arria, K. Kaltenbach et al., Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review, Addiction, vol.107, pp.5-27, 2012.

M. S. Mücke, J. P. Nagel, C. Siedentopf, D. Bühre, and . Hüseman, Neonatal Abstinence Syndrome: Twelve Years of Experience at a Regional Referral Center, Klin Padiatr, vol.228, pp.1-7, 2016.

C. Lejeune and L. Simmat-durand, Enquête sur les femmes enceintes substituées à la méthadone ou à la buprénorphine haut dosage et caractéristiques de leurs nouveau-nés, 2003.

, Vital signs: prescription painkiller o verdoses: a growing epidemic, especially among women, Centers for Disease Control and Prevention, 2016.

J. Y. Ko, S. W. Patrick, V. T. Tong, R. Patel, J. N. Lind et al., Incidence of Neonatal Abstinence Syndrome -28 States, 1999.

E. C. Ailes, A. L. Dawson, J. N. Lind, S. M. Gilboa, M. T. Frey et al., Opioid prescription claims among women of reproductive age, MMWR Morb Mortal Wkly Rep, vol.64, pp.37-41, 2008.

A. Oei, J. Craig, F. Lui, and K. , Profile of infants born to drug-using mothers: A state-wide audit, Journal of Paediatrics and Child Health, vol.49, pp.80-86, 2013.

S. W. Patrick, J. Dudley, P. R. Martin, F. E. Harrell, M. D. Warren et al., Prescription opioid epidemic and infant outcomes, Pediatrics, vol.135, pp.842-50, 2015.

C. E. Martin, N. Longinaker, and M. Terplan, Recent trends in treatment admissions for prescription opioid abuse during pregnancy, J. Subst. Abuse Treat, vol.48, pp.37-42, 2015.

I. Convertino, A. Capogrosso, A. Sansone, A. Marino, M. T. Galiulo et al., Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects, 2016.

P. R. Mcelhatton, The effects of benzodiazepine use during pregnancy and lactation, Reprod. Toxicol, vol.8, pp.461-475, 1994.

J. L. Rementeria and K. Bhatt, Withdrawal symptoms in neonates from intrauterine exposure to diazepam, J. Pediatr, vol.90, pp.123-126, 1977.

S. Pierog, O. Chandavasu, and I. Wexler, Withdrawal symptoms in infants with the fetal alcohol syndrome, J. Pediatr, vol.90, pp.630-633, 1977.

D. Ogunyemi and G. E. Hernandez-loera, The impact of antenatal cocaine use on maternal characteristics and neonatal outcomes, J. Matern. Fetal Neonatal Med, vol.15, pp.253-259, 2004.

F. D. Eyler, M. Behnke, C. W. Garvan, N. S. Woods, K. Wobie et al., Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure, Neurotoxicol. Teratol, vol.23, pp.399-411, 2001.

M. L. Hudak and R. C. Tan, Neonatal drug withdrawal, Pediatrics, vol.129, pp.540-560, 2012.

K. Kaltenbach and H. E. Jones, Neonatal Abstinence Syndrome : Presentation and Treatment Considerations, American Society of addiction Medicine, 2016.

P. Thaithumyanon, S. Limpongsanurak, P. Praisuwanna, and S. Punnahitanon, Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant, J. Med. Assoc. Thail, vol.88, pp.1506-1513, 2005.

D. J. Maguire, S. Taylor, K. Armstrong, E. Shaffer-hudkins, A. M. Germain et al., Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome, Neonatal Network, issue.5, 2016.

G. Fischer, R. Jagsch, H. Eder, W. Gombas, P. Etzersdorfer et al., Comparison of methadone and slow-release morphine maintenance in pregnant addicts, Addiction, vol.94, pp.231-239, 1999.

T. S. Lee, Slow-release morphine was not more effective than methadone in reducing neonatal abstinence syndrome, West. J. Med, 2000.

T. Binder and B. Vavrinkova, Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department, Neuro Endocrinol. Lett, vol.29, pp.80-86, 2008.

S. W. Patrick, R. E. Schumacher, B. D. Benneyworth, E. E. Krans, J. M. Mcallister et al., Neonatal abstinence syndrome and associated health care expenditures: United States, JAMA, vol.307, pp.1934-1974, 2000.

S. W. Patrick, M. M. Davis, C. U. Lehman, and W. O. Cooper, Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States, J Perinatol, vol.35, p.667, 2009.

E. M. Wachman and D. M. Schiff, Bringing attention to a need for a standardized treatment and weaning protocol for neonatal abstinence syndrome, Transl Pediatr, vol.5, issue.1, pp.12-15, 2016.

S. Sarkar and S. M. Donn, Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey, Journal of Perinatology, vol.26, pp.15-17, 2006.

H. H. Cho, J. P. O'connell, M. F. Cooney, and M. A. Inchiosa, Minimizing tolerance and withdrawal to prolonged pediatric sedation: case report and review of the literature, J.Intensive Care Med, vol.22, pp.173-179, 2007.

S. Micard and F. Brion, Management of the opioid withdrawal in the neonates: French and European survey, Arch Pediatr, vol.10, issue.3, pp.199-203, 2003.

L. S. Franck and J. Vilardi, Assessment and management of opioid withdrawal in ill neonates, Neonatal Netw, vol.14, issue.2, p.83, 1995.

K. A. Kaltenbach and L. P. Finnegan, Studies of prenatal drug exposure and environmental research issues: the benefits of integrating research within a treatment program, NIDA Res Monogr, vol.117, pp.259-70, 1992.

M. J. O'grady, J. Hopewell, and M. J. White, Management of neonatal abstinence syndrome: a national survey and review of practice, Arch Dis Child Fetal Neonatal, vol.94, pp.249-252, 2009.

K. Wolff, M. Farrell, and J. Marsden, A review of biological indicators of illicit drug use, practical considerations and clinical usefulness, Addiction, vol.94, issue.09, pp.1279-1298, 1999.

C. Lejeune, J. C. Ropert, S. Montamat, C. Floch-tudal, F. Mazy et al., Devenir médico-social de 59 nouveau-nés de mère toxicomane, J Gynecol Obstet Biol Reprod, vol.26, pp.395-404, 1997.

M. Green and F. Suffet, The neonatal narcotic withdrawal index: a device for the improvement of care in the abstinence syndrome, Am. J. Drug Alcohol Abuse, vol.8, pp.203-213, 1981.

L. S. Franck, S. K. Harris, D. J. Soetenga, J. K. Amling, and M. Curley, The Withdrawal Assessment Tool-1 (WAT-1): An Assessment Instrument for Monitoring Opioid and Benzodiazepine Withdrawal Symptoms in Pediatric Patients, Pediatric Critical Care Medicine, vol.9, issue.6, pp.573-580, 2008.

B. De-jonghe, D. Cook, C. Appere-de-vecchi, G. Guyatt, M. Meade et al., Using and understanding sedation scoring systems: a systematic review, Intensive Care Med, vol.26, pp.275-285, 2000.

A. Amigoni, M. C. Mondardini, I. Vittadello, F. Zaglia, E. Rossetti et al., Withdrawal Assessment Tool-1 Monitoring in PICU: A Multicenter Study on Iatrogenic Withdrawal Syndrome, Pediatr Crit Care Med, vol.18, 2017.

H. E. Jones and A. Fielder, Neonatal abstinence syndrome: Historical perspective, current focus, future directions, Prev Med, vol.80, pp.12-19, 2015.

, Committe on Drugs. Neontal drug withdrawal. Pediatrics, vol.101, p.107, 1998.

C. Lejeune, C. Floch-tudal, S. Montamat, C. Crenn-hebert, and A. M. Simonpoli, Management of drug addict pregnant women and their children, Review. French, vol.4, issue.3, pp.263-70, 1997.

U. M. Reddy, J. M. Davis, Z. Ren, and M. F. Greene, Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes, Obstetrics & Gynecology. 2017, vol.130, issue.1, pp.10-28

L. T. Mitrovi?, ?. Mikovi?, V. Mandi?, L. H. Avramovi?, D. ?e?ez et al., Neonatal Abstinence Syndrome -Diagnostic Dilemmas in the Maternity Ward, Srp Arh Celok Lek, vol.143, issue.9, pp.573-580, 2015.

D. Shah, S. Brown, N. Hagemeier, S. Zheng, A. Kyle et al., Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help? SpringerPlus, vol.5, p.854, 2016.

K. A. Yonkers, H. B. Howell, N. Gotman, and B. J. Rounsaville, Self-report of illicit substance use versus urine toxicology results from at-risk pregnant women, J Subst Use, vol.16, issue.05, pp.372-389, 2011.

S. Strano-rossi, Methods used to detect drug abuse in pregnancy : a brief review, Drug Alcohol Depend, vol.53, issue.03, pp.257-271, 1999.

I. Lacroix, A. Berrebi, C. Chaumerliac, M. Lapeyre-mestre, J. L. Montastruc et al., Buprenorphine in pregnant opioid-dependent women: first results of a prospective study. Society for the Study of Addiction, Addiction, vol.99, pp.209-214, 2004.

K. Kaltenbach, H. E. Jones, G. Fischer, and P. Selby, New Approaches in the Treatment of Opioid Dependency During Pregnancy, Heroin Addict Relat Clin Probl, vol.9, issue.3, pp.9-20, 2007.

M. E. Stabler, L. Long, I. Chertok, P. R. Giacobbi, C. Pilkerton et al.,

, Neonatal Abstinence Syndrome in West Virginia Substate Regions, The Journal of Rural Health, pp.1-10, 2007.

L. A. Devlin and J. M. Davis, A Practical Approach to Neonatal Opiate Withdrawal Syndrome, Am J Perinatol, pp.735-1631, 2017.

A. E. Burgos, B. L. Burke, and J. , Neonatal Abstinence Syndrome. NeoReviews, vol.10, pp.222-229, 2009.

E. Gomez-pomar and L. P. Finnegan, The epidemic of neonatal abstinence syndrom, historical references of it's origins, assessment and management. Front. Pediatr, vol.6, p.33, 2018.

C. Hurault-delarue, C. Damase-michel, L. Finotto, C. Guitard, C. Vayssière et al., Psychomotor developmental effects of prenatal exposure to psychotropic drugs: a study in EFEMERIS database, Fundamental & Clinical Pharmacology, vol.30, pp.476-482, 2016.

A. El-mohandes, A. Herman, M. N. El-khorazaty, P. S. Katta, D. White et al.,

, Prenatal care reduces the impact of illicit drug use on perinatal outcomes, J. Perinatol, vol.23, pp.354-60, 2003.

L. Marcellus, Care of substance-exposed infants: the current state of practice in Canadian hospitals, J Perinat Neonatal Nurs, vol.16, issue.03, pp.51-68, 2002.

R. Cicco and N. Stoehr, Neonatal abstinence syndrom clinical management document ; consensus panel. Gateway Health Plan, 2010.

E. Allocco, M. Melker, F. Rojas-miguez, M. S. Caitlin, K. A. Hahn et al., Comparison of neonatal abstinence syndrome manifestations in preterm versus term opioid exposed infants. Advances in neonatal care, vol.5, pp.329-336, 2016.

M. L. Velez, L. M. Jansson, J. Schroeder, and E. Williams, Prenatal methadone exposure and neonatal neurobehavioral functioning, Pediatr Res, vol.66, issue.6, pp.704-709, 2009.

J. J. Volpe, Teratogenic effects of drugs and passive addiction, Neurology of the Newborn, Volpe JJ, p.680, 1987.

M. Levy and M. Spino, Neonatal Withdrawal Syndrome: Associated Drugs and Pharmacologic Management, Pharmacotherapy, vol.13, issue.3, pp.202-211, 1993.

L. M. Jansson, M. Velez, and C. Harrow, The Opioid Exposed Newborn: Assessment and Pharmacologic Management, J Opioid Manag, vol.5, issue.1, pp.47-55, 2009.

A. H. Teague, A. J. Jnah, and D. Newberry, Intraprofessional Excellence in Nursing: Collaborative Strategies for Neonatal Abstinence Syndrome, vol.34, 2015.

J. Davis and L. Devlin, A Practical Approach to Neonatal Opiate Withdrawal Syndrome, American Journal of Perinatology. 2017, vol.35, issue.04, pp.324-330

S. W. Patrick, R. E. Schumacher, and J. D. Horbar,

K. A. Morrow, K. Ferrelli, A. P. Picarillo, M. Gupta, and R. F. Soll, Improving Care for Neonatal Abstinence Syndrome, Pediatrics, vol.137, issue.5, p.20153835, 2016.

E. Ista, M. Van-dijk, C. Gamel, D. Tibboel, and M. De-hoog, Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics: a literature review, Intensive Care Med, vol.33, pp.1396-1406, 2007.

W. K. Kraft, M. W. Stover, and J. M. Davis, Neonatal abstinence syndrom : pharmacologic strategies for the mother and infant. Seminars in perinatology, 2015.

S. L. Walsh, K. L. Preston, M. L. Stitzer, E. J. Cone, and G. E. Bigelow, Clinical pharmacology of buprenorphine: ceiling effects at high doses, Clin Pharmacol Ther, vol.55, issue.5, pp.569-80, 1994.

E. Gomez-pomar, L. P. Finnegan, L. Devlin, H. Bada, V. A. Concina et al., Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA, BMJ Open, 2017.

H. E. Jones, C. Seashore, J. E. Horton, E. , O. Grady et al., Brief Report: Psychometric Assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale, The American Journal on Addictions, pp.1-4, 2016.

H. E. Jones, C. Harrow, O. Grady, K. E. Crocetti, M. Jansson et al., Neonatal abstinence scores in opioid-exposed and nonexposed neonates: a blinded comparison, J Opioid Manag, vol.6, issue.6, pp.409-422, 2010.

L. M. Jansson, D. Pietro, J. A. Velez, M. Elko, A. Williams et al., Fetal Neurobehavioral Effects of Exposure to Methadone or Buprenorphine, Neurotoxicol Teratol, vol.33, issue.2, pp.240-243, 2011.

D. E. Gaalema, T. L. Scott, S. H. Heil, M. G. Coyle, K. Kaltenbach et al., Differences in the profile of neonatal abstinence syndrome signs in methadone-vs. buprenorphine-exposed infants, Addiction, vol.107, pp.53-62, 2012.

S. L. Wiegand, E. M. Stringer, A. M. Stuebe, H. E. Jones, C. Seashore et al., Buprenorphine and Naloxone Compared With Methadone Treatment in Pregnancy, Obstetrics and Gynecology, vol.125, 2015.

K. Johnson, C. Gerada, and A. Greenough, Substance misuse during pregnancy The British journal of psychiatry, vol.183, pp.187-189, 2003.

M. B. Sutter, L. Leeman, and A. Hsi, Neonatal opioid withdrawal syndrom, Obstet Gynecol Clin N Am, vol.41, pp.317-350, 2014.

A. Noormohammadi, A. Forinash, A. Yancey, E. Crannage, K. Campbell et al., Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy, Annals of Pharmacotherapy, vol.2016, pp.1-7

S. Kurath-koller, P. J. Mileder, L. P. Schmölzer, G. M. Urlesberger, B. Raith et al.,

, Active Somatic and Psychic Ear Acupuncture Points in Newborn Infants with Neonatal Abstinence Syndrome. The journal of alternative and complementary medicine, 201600.

S. Playfor, I. Jenkins, C. Boyles, I. Choonara, G. Davies et al., Consensus guidelines on sedation and analgesia in critically ill children, Intensive Care Med. 2006, vol.32, pp.1125-1136

B. Chisamore, S. Labana, S. Blitz, and A. Ordean, A Comparison of Morphine Delivery in Neonatal Opioid Withdrawal, Substance abuse: Research and treatment 2016:10(S1) 94) HAS. Femmes enceintes toxicomanes et périnatalité. HAS, 2007.

M. R. Grossman, A. K. Berkwitt, R. R. Osborn, Y. Xu, D. A. Esserman et al., An Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome, vol.139, p.6, 2017.

C. Mcpherson, Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All. Neonatal network, 1935.

L. Marcellus, Social ecological examination of factors that influence the treatment of newborns with neonatal abstinence syndrome. the Association of Women's Health, Obstetric and Neonatal Nurses, 2018.

L. M. Robins and J. L. Mills, Effect of in utero exposure to street drugs, Am J Public Health, vol.83, pp.1-32, 1993.

J. C. Vance, D. C. Chant, and D. I. Tudehope, Infants born to narcotic dependent mothers : physical growth patterns in the first 12 months of life, Journal of Paediatrics and Child Health, vol.33, pp.504-508, 1997.

S. M. Gauthier, C. R. Bauer, and D. S. Masinger, The Bayley scales of infantdevelopment.II: The Bayleyscales of infantdevelopment.II: Whereto start. Whereto start, Journalof Behavioural Pediatrics Journal of Behavioural Pediatrics, vol.20, p.75, 1920.

H. Wainer, Estimating coefficients in linear models : it don't make no nevermind, Psychol. Bull, vol.83, pp.2213-2217, 1976.

J. Murphy-oikonen and K. Mcqueen, Outpatient pharmacologic weaning for neonatal abstinence syndrome: a systematic review, Primary Health Care Research & Development, vol.2018, pp.1-9

A. Mehta, K. D. Forbes, and V. S. Kuppala, Neonatal Abstinence Syndrome Management From Prenatal Counseling to Postdischarge Follow-up Care: Results of a National Survey, Hospital Pediatrics. 2013, issue.3, pp.2154-1671

C. Lejeune, C. Floch-tudal, A. Crenn-hebert, and M. Simonpol, Réseaux ville-hôpital et projet social : l'expérience des réseaux périnatal et toxicomanie du nord des Hautsde-Seine autour des femmes enceintes abusant de substances psycho-actives, 2004.

R. T. , Intensive prenatal care may deliver healthy babies to pregnant drug abusers, JAMA, vol.265, pp.2773-2777, 1991.

L. P. Finnegan and . Women, Pregnancy and Methadone. Heroin Add & Rel Clin Probl, vol.2, issue.1, pp.1-8, 2000.

M. Cassen, J. M. Delile, E. Pohier, F. Facy, F. Villez et al.,

. Maternité, Alcoologie et Addictologie, vol.26, issue.2, pp.87-97, 2004.

M. Terplan, E. J. Mcnamara, and M. S. Chisolm, Pregnant and non-pregnant women with substance use disorders: the gap between treatment need and receipt, J Addict Dis, vol.31, issue.4, pp.342-351, 2012.

K. Dow, A. Ordean, J. Murphy-oikonen, J. Pereira, G. Koren et al.,

P. and T. R. , Neonatal abstinence syndrome clinical practice guidelines for Ontario, J Popul Ther Clin Pharmacol, issue.3, pp.488-506, 2012.

C. Lejeune, S. Montamat, and C. Guiton, Etablissement d'un réseau médico-social, ville hôpital, périnatal, Gyn Intern, vol.6, pp.97-105, 1997.

D. O. Regan, S. M. Ehrlich, and L. P. Finnegan, Infant of drug addicts : at risk for child abuse, neglect, and placement in foster care, Neurotoxicol Teratol, vol.9, pp.315-324, 1987.

S. K. Davis, Chemical dependency in women: a description of its effects and outcome on adequate parenting, J Subst Abuse Treat, vol.7, pp.225-257, 1990.

K. D'apolito, Neonatal Abstinence Syndrom: A Growing Problem, Neonatal Network, vol.35, p.5, 2016.

L. Marcellus, Special Issue on Neonatal Abstinence Syndrome, Neonatal Network, issue.5, 201635.

J. J. Mccarthy, M. H. Leamon, L. P. Finnegan, and C. Fassbender, Opioid Dependence and Pregnancy: Minimizing Stress on the Fetal Brain, American Journal of Obstetrics and Gynecology, 2016.

E. Mazurier, C. Chanal, M. Misraoui, and R. M. Toubin, De la femme à l'enfant, les liens interprofessionnels autour de la femme enceinte toxicomane, Arch Pediatr, vol.7, issue.2, pp.281-283, 2000.

S. M. Bagley, E. M. Wachman, E. Holland, and S. B. Brogly, Review of the assessment and management of neonatal abstinence syndrom. Addiction science and clinical practice, vol.9, p.19, 2014.

P. O. Anderson, Effect of breastfeeding on neonatal abstinence syndrome, Am J Health-Syst Pharm, vol.73, p.12, 2016.

G. Welle-strand, S. Skurtveit, H. Jones, H. Wall, B. Bakstad et al., Neontal outcomes following in utero exposure to methadone or buprenorphine : A national cohort study of opioid-agonist treatment of pregnant women in Norway from 1996 to 2009. Drug and Alcohol dependance, 2012.